Organovo Holdings Stock Today
| ONVO Stock | USD 0.37 0.02 5.13% |
Performance0 of 100
| Odds Of DistressOver 85
|
Organovo Holdings is selling at 0.37 as of the 17th of December 2024; that is 5.13 percent decrease since the beginning of the trading day. The stock's open price was 0.39. Organovo Holdings has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company was incorporated in 2007 and is headquartered in Solana Beach, California. Organovo Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 15.37 M outstanding shares of which 106.33 K shares are now shorted by private and institutional investors with about 0.47 trading days to cover. More on Organovo Holdings
Moving against Organovo Stock
Organovo Holdings cannot be verified against its exchange. Apparently, Organovo Holdings is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshOrganovo Stock Highlights
| Chairman | Keith Murphy |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
Organovo Holdings (ONVO) is traded on NASDAQ Exchange in USA. It is located in 11555 Sorrento Valley Road, San Diego, CA, United States, 92121 and employs 12 people. Organovo Holdings is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.99 M. Organovo Holdings conducts business under Biotechnology sector and is part of Health Care industry. The entity has 15.37 M outstanding shares of which 106.33 K shares are now shorted by private and institutional investors with about 0.47 trading days to cover.
Organovo Holdings currently holds about 26.19 M in cash with (14.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.01.
Check Organovo Holdings Probability Of Bankruptcy
Organovo Holdings Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Organovo Holdings market risk premium is the additional return an investor will receive from holding Organovo Holdings long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.29) |
Organovo Stock Against Markets
Try Other Suggestions
Organovo Holdings Corporate Management
| Vaidehi Joshi | Director Director | Profile | |
| MS JD | Gen Sec | Profile | |
| Curtis Tyree | Senior Development | Profile | |
| Jeffrey Miner | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.